accountLONDON -(Dow Jones)- The European Medicines Agency said Friday it has been formally notified by Wyeth Europa Ltd., a subsidiary of Pfizer Inc. (PFE), of its decision to withdraw its duplicate application for a centralized marketing authorization for the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to EU Drug Panel: Wyeth Withdraws Brilence Marketing Application
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account